Get a reply from this employer
Your resume and cover letter, tailored to exactly what they’re hiring for.
The START Center for Cancer Research seeks a Lead, Regulatory Operations (Remote) to guide the Regulatory Operations team, oversee complex submissions to IRB, FDA, and IBC, and drive process improvements. The role requires strong problem-solving, judgment, and independence.
As team lead, you will ensure timely submissions, train staff, review quality, and collaborate with cross-functional groups across START USA sites while supporting policy development and SOPs.
The START Center for Cancer Research (“START”) is the world’s largest early phase site network, fully dedicated to oncology clinical research. To date, over 45 therapies conducted at START locations have obtained FDA/EMA approval.
The START Center for Cancer Research is seeking a Lead, Regulatory Operations (Remote) who will serve as the regulatory subject-matter expert (SME) and provides guidance, training, and operational oversight to the Regulatory Operations team. This role oversees complex regulatory submissions, supports process improvement initiatives, delegates and prioritizes work as needed, performs quality reviews to ensure compliance and accuracy. The Lead will prepare and submit regulatory documents for new and ongoing clinical studies to the Institutional Review Board (IRB), US Food and Drug Administration (FDA), and Institutional Biosafety Committee (IBC). This role requires strong problem‑solving ability, sound judgment, and a high degree of independence. As team lead, ensure turnaround times are met, collect and review key metrics and continually improve processes to help achieve goals.
This is a remote role. The salary range for this role is $80,000 - $105,000. However, base pay may vary depending on multiple individualized factors including market location, job-related knowledge, skills, and experience.
Work Schedule: Monday-Friday 8:00am-5:00pm
Deeply rooted in community oncology centers globally, The START Center for Cancer Research provides access to specialized preclinical and early‑phase clinical trials of novel anti‑cancer agents. START clinical trial sites have conducted more than a thousand early‑phase clinical trials, including for 43 therapies that were approved by the FDA. START represents the world’s largest roster of Principal Investigators (PIs) across its eight clinical trial sites. Committed to accelerating passage from trials to treatments, START delivers hope to patients, families, and physicians around the world.
Learn more at STARTresearch.com.
We are an equal opportunity employer that welcomes and encourages diversity in the workplace. We do not discriminate on the basis of race, color, religion, marital status, age, national origin, ancestry, physical or mental disability, medical condition, pregnancy, genetic information, gender, sexual orientation, gender identity or expression, veteran status, or any other status protected under federal, state, or local law.